Yang et al. demonstrated that serum HGF levels were significantly elevated at POD 3 compared with preoperative values in pancreatic cancer [29]; however, postoperative change in HGF levels was not correlated with overall survival as evaluated via a multivariate analysis. The gene discussed is HGF; the disease is pancreatic neoplasm.